{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:31:06Z","timestamp":1792445466108,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.soc.2008.08.009","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T07:17:50Z","timestamp":1228375070000},"page":"175-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Surgical Management of Neurofibromatosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Colin M.","family":"Parsons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Canter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay\u00a0P.","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-4362.1980.tb01998.x","article-title":"Antique illustrations of neurofibromatosis","volume":"19","author":"Zanca","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.soc.2008.08.009_bib2","first-page":"64","article-title":"Observation on cancers","volume":"1","author":"Akenside","year":"1768","journal-title":"Medical Transactions Royal College of Physicians of London"},{"key":"10.1016\/j.soc.2008.08.009_bib3","article-title":"Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen (On multiple fibromas in the skin and their relationship to multiple neuromas)","author":"Recklinghausen","year":"1882","journal-title":"Berlin, A Hirschwald"},{"issue":"27","key":"10.1016\/j.soc.2008.08.009_bib5","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","article-title":"Von Recklinghausen neurofibromatosis","volume":"305","author":"Riccardi","year":"1981","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib6","first-page":"1","article-title":"Neurofibromatosis","volume":"6","year":"1987","journal-title":"Natl Inst Health Consens Dev Conf Consens Statement"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM198808043190505","article-title":"Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred","volume":"319","author":"Wertelecki","year":"1988","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"10.1016\/j.soc.2008.08.009_bib8","first-page":"284","article-title":"Neurofibromatosis update","volume":"2","author":"Riccardi","year":"1989","journal-title":"Neurofibromatosis"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jmg.27.5.307","article-title":"Segregation analysis of peripheral neurofibromatosis (NF1)","volume":"27","author":"Littler","year":"1990","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib10","first-page":"284","article-title":"Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants","volume":"42","author":"Riccardi","year":"1988","journal-title":"Am J Hum Genet"},{"issue":"6371","key":"10.1016\/j.soc.2008.08.009_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib12","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0002-9440(10)65507-1","article-title":"Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation","volume":"155","author":"Nielsen","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0002-9440(10)65508-3","article-title":"Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas","volume":"155","author":"Kourea","year":"1999","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib14","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.soc.2008.08.009_bib15","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI7610","article-title":"Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models","volume":"105","author":"DeClue","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00133486","article-title":"Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression","volume":"13","author":"Muir","year":"1995","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0888-7543(95)80104-T","article-title":"Genomic organization of the neurofibromatosis 1 gene (NF1)","volume":"25","author":"Li","year":"1995","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archderm.1977.01640060133020","article-title":"Segmental neurofibromatosis","volume":"113","author":"Miller","year":"1977","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.soc.2008.08.009_bib19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib20","first-page":"727","article-title":"Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis","volume":"63","author":"Evans","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","article-title":"Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients","volume":"70","author":"Friedman","year":"1997","journal-title":"Am J Med Genet"},{"issue":"8","key":"10.1016\/j.soc.2008.08.009_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","article-title":"Neurofibromatosis 1: clinical manifestations and diagnostic criteria","volume":"17","author":"Friedman","year":"2002","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R","article-title":"Neurofibromatosis type 1 and pregnancy","volume":"66","author":"Dugoff","year":"1996","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib25","doi-asserted-by":"crossref","first-page":"spc1","DOI":"10.1002\/dvdy.21537","article-title":"Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin","volume":"237","author":"Roth","year":"2008","journal-title":"Dev Dyn"},{"issue":"3 Pt 1","key":"10.1016\/j.soc.2008.08.009_bib26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the National Institutes of Health criteria\u00a0for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"issue":"Pt 6","key":"10.1016\/j.soc.2008.08.009_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von Recklinghausen neurofibromatosis. A\u00a0clinical and population study in south-east Wales","volume":"111","author":"Huson","year":"1988","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib29","first-page":"79","article-title":"Electron microscopical study on the tumor of von Recklinghausen's neurofibromatosis","volume":"24","author":"Kimura","year":"1974","journal-title":"Acta Pathol Jpn"},{"issue":"11","key":"10.1016\/j.soc.2008.08.009_bib30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","article-title":"Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases","volume":"137","author":"Wolkenstein","year":"2001","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0190-9622(80)80254-4","article-title":"Pathophysiology of neurofibromatosis. IV. Dermatologic insights into heterogeneity and pathogenesis","volume":"3","author":"Riccardi","year":"1980","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib32","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1212\/WNL.50.6.1755","article-title":"CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions","volume":"50","author":"Tonsgard","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.5-6-477","article-title":"Malignancy in neurofibromatosis type 1","volume":"5","author":"Korf","year":"2000","journal-title":"The Oncologist"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-3476(97)70092-1","article-title":"Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974\u20131994","volume":"131","author":"Needle","year":"1997","journal-title":"J Pediatr"},{"issue":"1\u20133","key":"10.1016\/j.soc.2008.08.009_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/B:NEON.0000041891.39474.cb","article-title":"Peripheral nerve tumors: management strategies and molecular insights","volume":"69","author":"Bhattacharyya","year":"2004","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0007-1226(83)90140-6","article-title":"The vascular features of plexiform neurofibroma with some observations on the importance of pre-operative angiography and the value of pre-operative intra-arterial embolisation","volume":"36","author":"Littlewood","year":"1983","journal-title":"Br J Plast Surg"},{"issue":"2A","key":"10.1016\/j.soc.2008.08.009_bib37","first-page":"949","article-title":"Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images","volume":"23","author":"Friedrich","year":"2003","journal-title":"Anticancer res"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7819-3-6","article-title":"Resection of small plexiform neurofibromas in neurofibromatosis type 1 children","volume":"3","author":"Friedrich","year":"2005","journal-title":"World J Surg Oncol"},{"issue":"2 Pt 1","key":"10.1016\/j.soc.2008.08.009_bib39","first-page":"L311","article-title":"Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level","volume":"276","author":"Gurujeyalakshmi","year":"1999","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pediatrneurol.2007.01.009","article-title":"Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas","volume":"36","author":"Babovic-Vuksanovic","year":"2007","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/01.WNL.0000042321.94839.78","article-title":"Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1","volume":"60","author":"Gupta","year":"2003","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.soc.2008.08.009_bib42","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/WNL.58.10.1461","article-title":"Plexiform neurofibromas in NF1: toward biologic-based therapy","volume":"58","author":"Packer","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.soc.2008.08.009_bib43","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02303627","article-title":"Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience","volume":"2","author":"Vauthey","year":"1995","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","article-title":"Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution","volume":"228","author":"Lewis","year":"1998","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jso.20971","article-title":"Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations","volume":"97","author":"Grobmyer","year":"2008","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jmg.36.3.197","article-title":"A clinical study of type 1 neurofibromatosis in northwest England","volume":"36","author":"McGaughran","year":"1999","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410070405","article-title":"Radiation-induced malignant and atypical peripheral nerve sheath tumors","volume":"7","author":"Foley","year":"1980","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006123-199807000-00035","article-title":"Neurogenic sarcomas: experience at the University of Toronto","volume":"43","author":"Angelov","year":"1998","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejrad.2003.12.001","article-title":"Imaging of peripheral nerve sheath tumors with pathologic correlation: pictorial review","volume":"52","author":"Pilavaki","year":"2004","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nic.2004.03.004","article-title":"Neuroimaging findings in neurofibromatosis type 1 and 2","volume":"14","author":"Rodriguez","year":"2004","journal-title":"Neuroimaging Clin N Am"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib53","first-page":"332","article-title":"Integrated imaging in peripheral nerve lesions in type 1 neurofibromatosis","volume":"103","author":"Iannicelli","year":"2002","journal-title":"Radiol Med (Torino)"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.68.3.353","article-title":"Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1","volume":"68","author":"Ferner","year":"2000","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib55","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0748-7983(03)00055-6","article-title":"Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours","volume":"29","author":"Cardona","year":"2003","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00003072-200106000-00009","article-title":"Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis","volume":"26","author":"Solomon","year":"2001","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-006-9161-x","article-title":"Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature","volume":"80","author":"Basu","year":"2006","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-005-0030-1","article-title":"Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours","volume":"33","author":"Brenner","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.soc.2008.08.009_bib59","series-title":"Soft tissue tumors","first-page":"1111","article-title":"Benign tumors of peripheral nerves: malignant tumors of the peripheral nerves","author":"Enziger","year":"2001"},{"issue":"10","key":"10.1016\/j.soc.2008.08.009_bib60","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3","article-title":"Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group","volume":"91","author":"Coindre","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib61","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R","article-title":"Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases","volume":"66","author":"Hruban","year":"1990","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00000658-199109000-00015","article-title":"The role of multimodality therapy in soft-tissue sarcoma","volume":"214","author":"Brennan","year":"1991","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib63","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/0360-3016(91)90323-V","article-title":"Brachytherapy and function-saving resection of soft tissue sarcoma arising in the limb","volume":"21","author":"Shiu","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5\u20136","key":"10.1016\/j.soc.2008.08.009_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/02841860310014732","article-title":"A systematic overview of radiation therapy effects in soft tissue sarcomas","volume":"42","author":"Strander","year":"2003","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.soc.2008.08.009_bib65","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1200\/JCO.1995.13.7.1537","article-title":"Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group","volume":"13","author":"Santoro","year":"1995","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib66","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0748-7983(05)80073-3","article-title":"Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis","volume":"21","author":"Doorn","year":"1995","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.107.135830","article-title":"Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin","volume":"326","author":"Wojtkowiak","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004311-199703540-00008","article-title":"Pheochromocytomas and anesthesia","volume":"35","author":"O'Riordan","year":"1997","journal-title":"Int Anesthesiol Clin"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib70","first-page":"973","article-title":"Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder","volume":"48","author":"Hyman","year":"2006","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib71","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"Rasmussen","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jmg.29.12.847","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the northwest of England over a 10-year period: higher incidence than previously thought","volume":"26","author":"Evans","year":"2005","journal-title":"Otol Neurotol"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib74","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jmg.37.12.897","article-title":"Neurofibromatosis type 2","volume":"37","author":"Evans","year":"2000","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00019052-200302000-00004","article-title":"Neurofibromatosis 2","volume":"16","author":"Baser","year":"2003","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nec.2004.02.008","article-title":"The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors","volume":"15","author":"Brooks","year":"2004","journal-title":"Neurosurg Clin N Am"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/mend.11.2.9886","article-title":"Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription","volume":"11","author":"Yen","year":"1997","journal-title":"Mol Endocrinol"},{"issue":"8","key":"10.1016\/j.soc.2008.08.009_bib78","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7","article-title":"Merlin differentially associates with the microtubule and actin cytoskeleton","volume":"51","author":"Xu","year":"1998","journal-title":"J Neurosci Res"},{"issue":"11","key":"10.1016\/j.soc.2008.08.009_bib80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0962-8924(01)02128-6","article-title":"Merlin: hanging tumor suppression on the Rac","volume":"11","author":"Sherman","year":"2001","journal-title":"Trends Cell Biol"},{"issue":"11","key":"10.1016\/j.soc.2008.08.009_bib81","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1177\/002215549904701113","article-title":"Expression of the neurofibromatosis type 2 gene in human tissues","volume":"47","author":"den Bakker","year":"1999","journal-title":"J Histochem Cytochem"},{"issue":"8","key":"10.1016\/j.soc.2008.08.009_bib82","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/00001756-199705260-00044","article-title":"Expression of schwannomin in lens and Schwann cells","volume":"8","author":"Claudio","year":"1997","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/hmg\/3.1.147","article-title":"The neurofibromatosis type 2 gene is inactivated in schwannomas","volume":"3","author":"Twist","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","article-title":"Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas","volume":"54","author":"Antinheimo","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib85","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib86","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet"},{"issue":"304","key":"10.1016\/j.soc.2008.08.009_bib87","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q J Med"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib88","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005072-199303000-00002","article-title":"Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases","volume":"52","author":"Sobel","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.soc.2008.08.009_bib89","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/adc.81.6.496","article-title":"Paediatric presentation of type 2 neurofibromatosis","volume":"81","author":"Evans","year":"1999","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib90","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2214\/ajr.165.4.7676998","article-title":"Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety","volume":"165","author":"Mautner","year":"1995","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.mao.0000185153.54457.16","article-title":"Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach","volume":"27","author":"Arts","year":"2006","journal-title":"Otol Neurotol"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib92","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006123-199704000-00007","article-title":"Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2","volume":"40","author":"Samii","year":"1997","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib93","first-page":"274","article-title":"Early proactive management of vestibular schwannomas in neurofibromatosis type 2","volume":"49","author":"Brackmann","year":"2001","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib94","first-page":"638","article-title":"Hearing preservation in neurofibromatosis type 2","volume":"19","author":"Slattery","year":"1998","journal-title":"Am J Otol"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib95","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","article-title":"Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates","volume":"60","author":"Mathieu","year":"2007","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","article-title":"Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2","volume":"96","author":"Baser","year":"2002","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1227\/01.NEU.0000255426.08926.95","article-title":"Safety of radiosurgery applied to conditions with abnormal tumor suppressor genes","volume":"60","author":"Rowe","year":"2007","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","article-title":"Management of the patient and family with neurofibromatosis 2: a consensus conference statement","volume":"19","author":"Evans","year":"2005","journal-title":"Br J Neurosurg"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib99","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000113112","article-title":"Clinical features and treatment of meningiomas in children: report of 12 cases and literature review","volume":"44","author":"Liu","year":"2008","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2","volume":"71","author":"Baser","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib101","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/jmg.37.12.944","article-title":"Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2)","volume":"37","author":"Evans","year":"2000","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib102","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.46.4.1072","article-title":"Schwannomatosis: a clinical and pathologic study","volume":"46","author":"MacCollin","year":"1996","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.soc.2008.08.009_bib103","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1212\/01.WNL.0000163982.78900.AD","article-title":"Diagnostic criteria for schwannomatosis","volume":"64","author":"MacCollin","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.soc.2008.08.009_bib104","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000070184.08740.E0","article-title":"Familial schwannomatosis: exclusion of the NF2 locus as the germline event","volume":"60","author":"MacCollin","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","article-title":"Germline mutation of INI1\/SMARCB1 in familial schwannomatosis","volume":"80","author":"Hulsebos","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib106","first-page":"133","article-title":"The SWI\/SNF complex\u2014chromatin and cancer","volume":"4","author":"Roberts","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib107","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/jnnp.2005.067017","article-title":"A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?","volume":"77","author":"Murray","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.soc.2008.08.009_bib108","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000245948","article-title":"Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2","volume":"195","author":"Wolkenstein","year":"1997","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib109","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3171\/jns.1998.89.1.0036","article-title":"Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?","volume":"89","author":"Seppala","year":"1998","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.soc.2008.08.009_bib110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.surneu.2003.11.020","article-title":"Management of patients with schwannomatosis: report of six cases and review of the literature","volume":"62","author":"Huang","year":"2004","journal-title":"Surgical neurology"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.soc.2008.08.009_bib112","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.nrl.0000195830.22432.a5","article-title":"Neurofibromatosis types 1 and 2","volume":"12","author":"Yohay","year":"2006","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.soc.2008.08.009_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.1991.tb00888.x","article-title":"Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease)","volume":"19","author":"Fuller","year":"1991","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.soc.2008.08.009_bib114","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.wnl.0000201190.89751.41","article-title":"Increasing the specificity of diagnostic criteria for schwannomatosis","volume":"66","author":"Baser","year":"2006","journal-title":"Neurology"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320708001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320708001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:54:16Z","timestamp":1760961256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320708001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1055320708001002"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2008.08.009","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Management of Neurofibromatosis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2008.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}